OncoClear
Back to list

Sarcoma

Rare Cancer

Category: 軟部組織ICD-10: C49

Overview

Sarcomas are malignant tumors arising from mesenchymal tissues including bone, muscle, fat, blood vessels, and nerves. Over 50 histological subtypes exist, accounting for about 1% of all adult cancers. They most commonly occur in the extremities, retroperitoneum, and trunk.

Symptoms

A painless lump or swelling in the extremities or trunk is the most common initial presentation. As the tumor enlarges, pain and functional impairment from compression of adjacent structures may develop.

Diagnosis

MRI evaluates the mass characteristics and extent, followed by core needle or incisional biopsy for histological diagnosis. Molecular testing for specific fusion genes (e.g., SYT-SSX) aids in subtype classification.

Treatments

Wide surgical excision with adequate margins is the cornerstone of treatment. High-grade tumors may receive neoadjuvant or adjuvant chemotherapy (doxorubicin plus ifosfamide). Radiation therapy is used pre- or post-operatively for local control.

Latest Research & Approaches

Trabectedin and eribulin have shown efficacy in liposarcoma and leiomyosarcoma. Tazemetostat (EZH2 inhibitor) is approved for INI1-negative epithelioid sarcoma.

Sources & References

NCI - Soft Tissue Sarcoma Treatment
Sarcoma Foundation of America
NCCN Guidelines: Soft Tissue Sarcoma

Hospitals with Treatment Experience

The following hospitals have documented treatment experience for this cancer (based on DPC public data and hospital cancer registry).

National Cancer Center Hospital

東京都 中央区

Website

Osaka International Cancer Institute

大阪府 大阪市

Website

Shizuoka Cancer Center

静岡県 駿東郡長泉町

Website

The Cancer Institute Hospital of JFCR

東京都 江東区

Website

Aichi Cancer Center

愛知県 名古屋市

Website

Kanagawa Cancer Center

神奈川県 横浜市

Website

Saitama Cancer Center

埼玉県 北足立郡伊奈町

Website

National Hospital Organization Kyushu Cancer Center

福岡県 福岡市

Website

Kumamoto University Hospital

熊本県 熊本市

Website

Mie University Hospital

三重県 津市

Website

Source: Ministry of Health, Labour and Welfare DPC Public Data / National Cancer Center Hospital Cancer Registry

Related Clinical Trials